Abstract
Marihuana use involves more than one substance. Not only is tetrahydrocannabinol (THC), the active psychoactive component, present, but also one or both other major cannabinoids, cannabidiol (CBD) and cannabinol (CBN).At present, evidence indicates that neither of these other two cannabinoids affects the action of THC. For practical purposes, THC alone is a model for the psychoactive action of marihuana. Alcohol is the social drug most used with marihuana, such use often being deliberate. Both have similar intoxicating effects, but these additive effects have not led to serious interactions. Stimulants often reverse some of the effects of THC, but the “high” from cocaine may be additive to that from THC. The interaction is so mild that no pattern of combined use has appeared. The same is true of the hallucinogen phencyclidine. So far as therapeutic drugs are concerned, few data are available. Although medical marihuana is not officially approved, marihuana has been tried empirically for treating a variety of medical disorders, such as nausea and vomiting associated with cancer chemotherapy, wasting syndrome associated with AIDS, and spasticity from neurological diseases. In each instance, other drugs are also present. So far, no adverse interactions from such use have been reported. However, this might not reflect the true prevalence. Unless one looks for something, one is not likely to find it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hollister, L. E. (1976) Interactions of delta-9-tetrahydrocannabinol with other drugs. Ann. NY Acad. Sci. 281, 212–218.
Nahas, G. C. (1984) Marihuana in Science and Medicine Raven, New York, pp.189–197.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M., Melvin, B., De Costa, B. R. and Rice, K. C. (1960) Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1931–1936.
Holleltt, A. C., Bidaut-Russell, M., Devane, W. A., Melvin, L. S., Johnson, M. R., and Herkenham, M. (1960) The cannabinoid receptor, biochemical, anatomical and behavioral characterization. Trends Neurosci. 13, 420–423.
Devane, W. A. (1994) New dawn of cannabinoid pharmacology. Trends Pharmacol. Sci. 15, 40–41.
Bornheim, L. M., Kim, K. Y., Perottti, B. Y. T., and Benet, L. Z. (1994) Effect of cannabidiol (CBD) pretreatment on the kinetics of tetrahydrocannabinol (THC) metabolites in brain. Can. J. Physiol. Pharmacol. 72 (suppl 1) 292.
Agurell, S., Carlsson, S., Lindgren, J. E., Ohlssson, A., Gillespie, H., and Hollister, L. E. (1981) Interactions of delta-1-tetrahydrocannabinol cannabinol and cannabinol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37, 1090–1091.
Hunt, R. A., Jones, R. T., Herning, R. I., and Bachman, J. (1981) Evidence that cannabidiol does not significanctly alter the pharmacokinetics of tetrahydrocannabinol in man. J. Pharmacokinetics Biopharmaceutics 9, 245–260.
Hollister, L. E. (1973) Cannabidiol and cannabinol in man. Experientia 29, 825–826.
Hollister, L. E. and Gillespie, H. K. (1975) Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabidiol and cannabinol. Clin Pharmacol. Ther. 18, 80–82.
Doty, P., Dykstra, L. A., and Picker, M. J. (1992) Delta-9-tetrahydrocannabinol interactions with phencyclidine and ethanol. Effects on accuracy and rate of responding. Pharmacol. Biochem. Behay. 43, 61–70.
Nishikami, J., Hamajima, K., Watanabe, K., Yamamoto, I., and Yoshimura, H. (1987) The interaction of cannabinoids with various drugs. J. Pharm. Sci. 76, S43.
Pertwee, R. G. and Greentree, R. G. (1988) Delta-9-tetrahydrocannabinol-induced caltalepsy in mice enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology 27. 486–491.
Lukas, S., Sholar, M., Kouri, E., and Mendelson, J. H. (1992) Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. Pharmacologist, 34, abstract 386.
Foltin, R. W., Fischman, M. W., and Kelly, T. H. (1992) Behavior effects of ethanol and marihuana, alone and in combination with cocaine in humans. Proc. Committee on Problems of Drug Dependence. NIDA Res. Monograph 109, 218.
Yamamoto, I, Umebayashi, E., Watanebe, E., and Yoshimura, R. (1988) Interactions of cannabis extract, delta-9-tetrahydrocannabinol and 11-hydroxy-delta-8-tetrahydrocannabinol with methamphetamine in mice. Commun. Subst. Abuse 9, 107–116.
Godley, P. J., Moore, E. S., Wooworth, J. R., and Fineg, J. (1991) Effects of ethanol and delta-9-tetrahydrocannabinol on phencyclidine disposition in dogs. Biopharm. Drug Dispos. 12, 189–199.
Lane, M., Vogal, C. L., Ferguson, J., Dransow, S., Saiers, J. L., Hamm, J., Salva, K., Wiernik, P. H., Holroyde, C. P., Hammill, S., Shepherd, K., and Plasse, T. (1990) Dronabinol and prochlorperazine in combination for treatment of cancer. J. Pain Symptom Manage 6, 352–359.
Vinciguerra, V., Moore, T., and Brennan, E. (1988) Inhalation marihuana as an antiemetic for cancer chemotherapy. NY State J. Med. 88, 525–528.
Gorter, R. (1991) Management of anorexia-cachexia associated with cancer and HIV infection. Oncology 5 (suppl 9), 13–16.
Mattes, R. D., Engelmann, K., Shaw, L. M., and Elsoholy, M. A. (1994) Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behay. 49, 187–195.
Ungerleider, J. T., Andyrsiak, T., Fairbanks, L., Ellison, G. W. and, Myers, L. W. (1987) Delta-9-THC in the treatment of spasticity associated with multiple sclerosis. Adv. Alcohol Substance Abuse 7 (1), 39–50.
Meinck, H., Schonle, P. W., and Conrad, B. (1989) Effect of cannabis of spasticity and ataxia in multiple sclerosis. J. Neurol. 239, 120–122.
Jaeger, W., Benet, L. Z., and Bornheim, L. M. (1996) Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Xenobiotica 26, 275–284.
Lacoursiere, R. B. and Swatek, R. (1983) Adverse interaction between disulfiram and marihuana: a case report. Am. J. Psychiatry 140, 243–244.
Stoll, A. L., Cole, J. O., and Lukas, S. L. (1991) Letter. A case of mania as a result of fluoxetine-marihuana interaction. J. Clin Psychiatr. 52, 280–281.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hollister, L.E. (1999). Interactions of Marihuana and THC with Other Drugs. In: Nahas, G.G., Sutin, K.M., Harvey, D., Agurell, S., Pace, N., Cancro, R. (eds) Marihuana and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-710-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-59259-710-9_27
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5717-0
Online ISBN: 978-1-59259-710-9
eBook Packages: Springer Book Archive